EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Hypertension and Kidney Function After Living Kidney Donation

Amit X Garg, Jennifer B Arnold, Meaghan S Cuerden, Christine Dipchand, Liane S Feldman, John S Gill, Martin Karpinski, Scott Klarenbach, Greg Knoll, Charmaine E Lok, Matthew Miller, Mauricio Monroy-Cuadros und 5 weitere

JAMA · 23.07.2024 · 332 (4) · 287

DOI: 10.1001/jama.2024.8523 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, erschienen am 23.07.2024. Verfasst von Amit X Garg und 16 weiteren Autor:innen. Beteiligte Einrichtung: Lawson Health Research Institute and London Health Sciences, London, Ontario, Canada. Hauptthemen laut MEDLINE: Hypertension, Living Donors, Nephrectomy, Renal Insufficiency. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Recent guidelines call for better evidence on health outcomes after living kidney donation.

Objective

To determine the risk of hypertension in normotensive adults who donated a kidney compared with nondonors of similar baseline health. Their rates of estimated glomerular filtration rate (eGFR) decline and risk of albuminuria were also compared. Design, Setting, and Participants Prospective cohort study of 924 standard-criteria living kidney donors enrolled before surgery and a concurrent sample of 396 nondonors. Recruitment occurred from 2004 to 2014 from 17 transplant centers (12 in Canada and 5 in Australia); follow-up occurred until November 2021. Donors and nondonors had the same annual schedule of follow-up assessments. Inverse probability of treatment weighting on a propensity score was used to balance donors and nondonors on baseline characteristics. Exposure Living kidney donation. Main Outcomes and Measures Hypertension (systolic blood pressure [SBP] ≥140 mm Hg, diastolic blood pressure [DBP] ≥90 mm Hg, or antihypertensive medication), annualized change in eGFR (starting 12 months after donation/simulated donation date in nondonors), and albuminuria (albumin to creatinine ratio ≥3 mg/mmol [≥30 mg/g]).

Results

Among the 924 donors, 66% were female; they had a mean age of 47 years and a mean eGFR of 100 mL/min/1.73 m 2 . Donors were more likely than nondonors to have a family history of kidney failure (464/922 [50%] vs 89/394 [23%], respectively). After statistical weighting, the sample of nondonors increased to 928 and baseline characteristics were similar between the 2 groups. During a median follow-up of 7.3 years (IQR, 6.0-9.0), in weighted analysis, hypertension occurred in 161 of 924 donors (17%) and 158 of 928 nondonors (17%) (weighted hazard ratio, 1.11 [95% CI, 0.75-1.66]). The longitudinal change in mean blood pressure was similar in donors and nondonors. After the initial drop in donors’ eGFR after nephrectomy (mean, 32 mL/min/1.73 m 2 ), donors had a 1.4-mL/min/1.73 m 2 (95% CI, 1.2-1.5) per year lesser decline in eGFR than nondonors. However, more donors than nondonors had an eGFR between 30 and 60 mL/min/1.73 m 2 at least once in follow-up (438/924 [47%] vs 49/928 [5%]). Albuminuria occurred in 132 of 905 donors (15%) and 95 of 904 nondonors (11%) (weighted hazard ratio, 1.46 [95% CI, 0.97-2.21]); the weighted between-group difference in the albumin to creatinine ratio was 1.02 (95% CI, 0.88-1.19). Conclusions and Relevance In this cohort study of living kidney donors and nondonors with the same follow-up schedule, the risks of hypertension and albuminuria were not significantly different. After the initial drop in eGFR from nephrectomy, donors had a slower mean rate of eGFR decline than nondonors but were more likely to have an eGFR between 30 and 60 mL/min/1.73 m 2 at least once in follow-up. Trial Registration ClinicalTrials.gov Identifier: NCT00936078

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionLiving DonorsNephrectomyRenal InsufficiencyAdultFemaleHumansMaleMiddle AgedAlbuminuriaAntihypertensive AgentsBlood PressureGlomerular Filtration RateKidneyKidney TransplantationProspective StudiesQuality of Life

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Lawson Health Research Institute and London Health Sciences, London, Ontario, Canada.
  • ICES, Ontario, Canada.
  • Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Division of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Department of Research Methods, Evidence and Uptake, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada.

Förderung

  • CIHR

Zitieren

APA

Garg, A. X., Arnold, J. B., Cuerden, M. S., Dipchand, C., Feldman, L. S., Gill, J. S., Karpinski, M., Klarenbach, S., Knoll, G., Lok, C. E., Miller, M., Monroy-Cuadros, M., Nguan, C., Prasad, G. V. R., Sontrop, J. M., Storsley, L., & Boudville, N. (2024). Hypertension and Kidney Function After Living Kidney Donation. JAMA, 332(4), 287. https://doi.org/10.1001/jama.2024.8523

Vancouver

Garg AX, Arnold JB, Cuerden MS, Dipchand C, Feldman LS, Gill JS, et al. Hypertension and Kidney Function After Living Kidney Donation. JAMA. 2024;332(4):287. doi:10.1001/jama.2024.8523

BibTeX
@article{Garg2024,
  author = {Garg, Amit X and Arnold, Jennifer B and Cuerden, Meaghan S and Dipchand, Christine and Feldman, Liane S and Gill, John S and Karpinski, Martin and Klarenbach, Scott and Knoll, Greg and Lok, Charmaine E and Miller, Matthew and Monroy-Cuadros, Mauricio and Nguan, Christopher and Prasad, G V Ramesh and Sontrop, Jessica M and Storsley, Leroy and Boudville, Neil},
  title = {Hypertension and Kidney Function After Living Kidney Donation},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {4},
  pages = {287},
  doi = {10.1001/jama.2024.8523}
}
Kostenlos starten →